Market Analysis
In 2022, the global Exosome Diagnostic and Therapeutics market was valued at approximately US$ 101.1 million.
It is projected to grow exponentially, reaching US$ 760.6 million by 2029, reflecting a robust Compound
Annual Growth Rate (CAGR) of 33.4% during the forecast period (2023–2029).
This growth is primarily driven by increased R&D activities, rising awareness of liquid biopsy technologies, and the expanding applications of exosomes in precision medicine.
The impact of COVID-19 and the Russia-Ukraine war has been taken into consideration in determining these figures.
